FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * LACORTE BLAIR 2. Issuer Name and Ticker or Trading Symbol CF Finance Acquisition Corp. III [ LIDR ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)         (First)         (Middle)
13063 VENTURA BLVD
3. Date of Earliest Transaction (MM/DD/YYYY)
8/16/2021
(Street)
STUDIO CITY, CA 916042238
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/16/2021    A    1405484  A $37.2080 (1) 1405484  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     77519      8/16/2021 (2) 5/31/2027  Common Stock  77519  $37.2080 (2) 77519  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     19382      8/16/2021 (3) 5/7/2028  Common Stock  19382  $37.2080 (3) 19382  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     30362      8/16/2021 (4) 9/17/2028  Common Stock  30362  $37.2080 (4) 30362  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     108525      8/16/2021 (5) 2/27/2029  Common Stock  108525  $37.2080 (5) 108525  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     20930      8/16/2021 (6) 7/1/2029  Common Stock  20930  $37.2080 (6) 20930  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     30481      8/16/2021 (7) 4/9/2030  Common Stock  30481  $37.2080 (7) 30481  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     6497789      8/16/2021 (8) 9/30/2030  Common Stock  6497789  $37.2080 (8) 6497789  D   
Stock Option (Right to Buy)  $7.0008  8/16/2021    A     11162      8/16/2021 (9) 4/5/2031  Common Stock  11162  $37.2080 (9) 11162  D   

Explanation of Responses:
(1)  Received in exchange for 377,737 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080
(2)  Received in exchange for stock options to acquire 20,834 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested.
(3)  Received in exchange for stock options to acquire 5,209 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested.
(4)  Received in exchange for stock options to acquire 8,160 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on September 18, 2022.
(5)  Received in exchange for stock options to acquire 29,167 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on January 1, 2023.
(6)  Received in exchange for stock options to acquire 5,625 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on March 18, 2023.
(7)  Received in exchange for stock options to acquire 8,192 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are fully vested.
(8)  Received in exchange for stock options to acquire 1,746,342 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on December 10, 2023.
(9)  Received in exchange for stock options to acquire 3,000 shares of AEye Technologies, Inc. ("AEye Technologies") in connection with the merger of AEye Technologies into AEye, Inc. (the "Company") pursuant to the exchange ratio set forth in the Agreement and Plan of Merger between AEye Technologies and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $37.2080. These stock options are partially vested and will fully vest on February 16, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LACORTE BLAIR
13063 VENTURA BLVD
STUDIO CITY, CA 916042238
X
Chief Executive Officer

Signatures
/s/ Blair LaCorte 8/27/2021
**Signature of Reporting Person Date
AEye (NASDAQ:LIDR)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more AEye Charts.
AEye (NASDAQ:LIDR)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more AEye Charts.